{"version":"1.0","type":"link","title":"The advantages and limitations of the new FIGO 2023 staging system for endometrial carcinoma from the perspective of the clinician and pathologist.","author_name":"Hruda M 외","author_url":"https://prs-insight.online/author/Hruda%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/88400","thumbnail_width":1200,"thumbnail_height":630}